The study included 183 patients with severe aplastic anemia who were treated from 2000 to 2008.
此研究纳入了2000年到2008年因严重的获得性再生障碍性贫血而接受治疗的183名患者。
Variations in telomere length have been reported in severe aplastic anemia but their clinical significance is unknown.
曾有报道称重度再障中端粒长度存有差异，但其临床意义未知。
Objective To evaluate the long term outcome of immunosuppressive therapy (IST) in patients with severe aplastic anemia (SAA).
目的评价重型再生障碍性贫血(SAA)患者免疫抑制治疗(ist)后的远期疗效。
Objective:To investigate the efficacy of unrelated HLA non-identical cord blood transplantation in severe aplastic anemia (SAA).
目的 ：观察HLA位点不相合的非亲缘脐血细胞移植治疗重型再生障碍性贫血 （SAA）的疗效。
Objective To observe the curative effect of the therapy of replenishing qi and blood combined with stanozolol on severe aplastic anemia.
目的观察中药补肾活血方治疗免疫介导型再生障碍性贫血小鼠的疗效，并探讨其作用机制。
Objective:To investigate efficacy of unrelated donor allogeneic peripheral blood stem cell transplantation(UD-PBSCT) in treatment of severe aplastic anemia(SAA).
目的：探讨非亲缘供者外周血造血干细胞移植（UD-PBSCT）治疗重型再生障碍性贫血（SAA）的可行性。
Severe aplastic anemia can be cured by haematopoietic stem cell transplantation. Synegenic HSCT is the best choice for severe aplastic anemia and chronic aplastic anemia.
造血干细胞移植是治愈重型再障的主要手段，同基因造血干细胞移植也适合慢性再障。
Objective: to investigate the correlation between colony stimulating activities of serum from patients with severe aplastic anemia (SAA) and their responses to immunosuppressive therapy (IST).
目的：探讨严重型再生障碍性贫血(SAA)患者血清集落刺激活性与免疫抑制治疗(ist)疗效的关系。
Aplastic anemia, severe combined immunodeficiency and hemoglobin disorders, for example, involve deficiencies of specific immune cells in the blood.
例如再生障碍性贫血、重症联合免疫缺陷和血红蛋白病等血中缺乏特定的免疫细胞。
Aplastic anemia, severe combined immunodeficiency and hemoglobin disorders, for example, involve deficiencies of specific immune cells in the blood.
例如再生障碍性贫血、重症联合免疫缺陷和血红蛋白病等血中缺乏特定的免疫细胞。
应用推荐